Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 53


National surveillance of health care-associated infections in Egypt: Developing a sustainable program in a resource-limited country.

Talaat M, El-Shokry M, El-Kholy J, Ismail G, Kotb S, Hafez S, Attia E, Lessa FC.

Am J Infect Control. 2016 Jun 20. pii: S0196-6553(16)30294-2. doi: 10.1016/j.ajic.2016.04.212. [Epub ahead of print]


Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.

Hunter JC, Mu Y, Dumyati GK, Farley MM, Winston LG, Johnston HL, Meek JI, Perlmutter R, Holzbauer SM, Beldavs ZG, Phipps EC, Dunn JR, Cohen JA, Avillan J, Stone ND, Gerding DN, McDonald LC, Lessa FC.

Open Forum Infect Dis. 2016 Jan 18;3(1):ofv196. doi: 10.1093/ofid/ofv196. eCollection 2016 Jan.


Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013.

Vallabhaneni S, Almendares O, Farley MM, Reno J, Smith ZT, Stein B, Magill SS, Smith RM, Cleveland AA, Lessa FC.

Epidemiol Infect. 2016 May;144(7):1440-4. doi: 10.1017/S0950268815003027. Epub 2015 Nov 26.


Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection.

Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC.

Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113. doi: 10.1093/ofid/ofv113. eCollection 2015 Sep.


Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.

Baggs J, Yousey-Hindes K, Ashley ED, Meek J, Dumyati G, Cohen J, Wise ME, McDonald LC, Lessa FC.

Vaccine. 2015 Nov 17;33(46):6241-9. doi: 10.1016/j.vaccine.2015.09.078. Epub 2015 Oct 9.


Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection After Recent Discharge From an Acute-Care Hospitalization, 2011-2013.

Epstein L, Mu Y, Belflower R, Scott J, Ray S, Dumyati G, Felsen C, Petit S, Yousey-Hindes K, Nadle J, Pasutti L, Lynfield R, Warnke L, Schaffner W, Leib K, Kallen AJ, Fridkin SK, Lessa FC.

Clin Infect Dis. 2016 Jan 1;62(1):45-52. doi: 10.1093/cid/civ777. Epub 2015 Sep 3.


Twenty Years of Active Bacterial Core Surveillance.

Langley G, Schaffner W, Farley MM, Lynfield R, Bennett NM, Reingold A, Thomas A, Harrison LH, Nichols M, Petit S, Miller L, Moore MR, Schrag SJ, Lessa FC, Skoff TH, MacNeil JR, Briere EC, Weston EJ, Van Beneden C.

Emerg Infect Dis. 2015 Sep;21(9):1520-8. doi: 10.3201/eid2109.141333.


Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance.

Langley G, Besser J, Iwamoto M, Lessa FC, Cronquist A, Skoff TH, Chaves S, Boxrud D, Pinner RW, Harrison LH.

Emerg Infect Dis. 2015 Sep;21(9):1582-8. doi: 10.3201/eid2109.150570.


Burden of Clostridium difficile infection in the United States.

Lessa FC, Winston LG, McDonald LC; Emerging Infections Program C. difficile Surveillance Team.

N Engl J Med. 2015 Jun 11;372(24):2369-70. doi: 10.1056/NEJMc1505190. No abstract available.


The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program.

Slayton RB, Scott RD, Baggs J, Lessa FC, McDonald LC, Jernigan JA.

Infect Control Hosp Epidemiol. 2015 Jun;36(6):681-7. doi: 10.1017/ice.2015.43. Epub 2015 Mar 18.


Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations.

Lessa FC, Mu Y, Winston LG, Dumyati GK, Farley MM, Beldavs ZG, Kast K, Holzbauer SM, Meek JI, Cohen J, McDonald LC, Fridkin SK.

Open Forum Infect Dis. 2014 Jul 28;1(2):ofu048. doi: 10.1093/ofid/ofu048. eCollection 2014 Sep.


Burden of Clostridium difficile infection in the United States.

Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC.

N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.


The epidemiology of Clostridium difficile infection inside and outside health care institutions.

Gerding DN, Lessa FC.

Infect Dis Clin North Am. 2015 Mar;29(1):37-50. doi: 10.1016/j.idc.2014.11.004. Epub 2015 Jan 9. Review.


Infection prevention practices in neonatal intensive care units reporting to the national healthcare safety network.

Hocevar SN, Lessa FC, Gallagher L, Conover C, Gorwitz R, Iwamoto M.

Infect Control Hosp Epidemiol. 2014 Sep;35(9):1126-32. doi: 10.1086/677636. Epub 2014 Jul 25.


NAP1 strain type predicts outcomes from Clostridium difficile infection.

See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, Holzbauer S, Dunn J, Farley MM, Lyons C, Johnston H, Phipps E, Perlmutter R, Anderson L, Gerding DN, Lessa FC.

Clin Infect Dis. 2014 May;58(10):1394-400. doi: 10.1093/cid/ciu125. Epub 2014 Mar 5.


Clostridium difficile infection among children across diverse US geographic locations.

Wendt JM, Cohen JA, Mu Y, Dumyati GK, Dunn JR, Holzbauer SM, Winston LG, Johnston HL, Meek JI, Farley MM, Wilson LE, Phipps EC, Beldavs ZG, Gerding DN, McDonald LC, Gould CV, Lessa FC.

Pediatrics. 2014 Apr;133(4):651-8. doi: 10.1542/peds.2013-3049. Epub 2014 Mar 3.


Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.

Cohen J, Limbago B, Dumyati G, Holzbauer S, Johnston H, Perlmutter R, Dunn J, Nadle J, Lyons C, Phipps E, Beldavs Z, Clark LA, Lessa FC; CDC's Clostridium difficile Infection Surveillance Investigators.

J Clin Microbiol. 2014 Feb;52(2):632-4. doi: 10.1128/JCM.02177-13. Epub 2013 Nov 20.


Incidence and pathogen distribution of healthcare-associated infections in pilot hospitals in Egypt.

See I, Lessa FC, ElAta OA, Hafez S, Samy K, El-Kholy A, El Anani MG, Ismail G, Kandeel A, Galal R, Ellingson K, Talaat M.

Infect Control Hosp Epidemiol. 2013 Dec;34(12):1281-8. doi: 10.1086/673985. Epub 2013 Oct 30.


Trends in invasive methicillin-resistant Staphylococcus aureus infections.

Iwamoto M, Mu Y, Lynfield R, Bulens SN, Nadle J, Aragon D, Petit S, Ray SM, Harrison LH, Dumyati G, Townes JM, Schaffner W, Gorwitz RJ, Lessa FC.

Pediatrics. 2013 Oct;132(4):e817-24. doi: 10.1542/peds.2013-1112. Epub 2013 Sep 23. Review.


National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011.

Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S; Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators.

JAMA Intern Med. 2013 Nov 25;173(21):1970-8. doi: 10.1001/jamainternmed.2013.10423.

Items per page

Supplemental Content

Loading ...
Support Center